1887

Chapter 27 : Effects on Connective Tissue Structures

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Effects on Connective Tissue Structures, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817817/9781555812317_Chap27-1.gif /docserver/preview/fulltext/10.1128/9781555817817/9781555812317_Chap27-2.gif

Abstract:

Quinolones have the potential to damage cartilage as well as tendons, thus being able to cause unusual forms of adverse drug reactions. Less is known about the effects on the epiphyseal growth plate, tendons, and other connective tissue structures, than about quinolone-induced lesions of the immature articular cartilage in animals. The current knowledge about the various target tissues is summarized in this chapter, but first, some brief general remarks about pharmacokinetics in experimental animals and humans and about the hypothetical mechanism of the toxic effects on connective tissue structures are given. The exact mechanism of quinolone-induced arthropathy or tendopathy is still unknown. Effects on the epiphyseal growth plate have also been reported after treatment with moxifloxacin in immature dogs. When beagles aged 10 to 12 weeks were treated with moxifloxacin, degeneration of the matrix as well as the chondrocytes was observed in the epiphyseal growth plates; however, no such effects were found in 18 to 22-week-old dogs under otherwise identical conditions. Results were similar for the ciprofloxacin treated dogs as well as the magnesium-deficient dogs. These findings support our hypothesis that quinolone-induced toxic effects on connective tissue structures are caused by the magnesium-antagonistic effects of these antibacterial agents. In summary, human experience with ciprofloxacin seems to indicate that no or minimal risks for quinolone-induced arthropathy exist. Another toxic reaction of a connective tissue structure is tendinopathy. The main sources of information are case reports, compilations from administrative authorities, or isolated retrospective studies that cover only the older compounds.

Citation: Stahlmann R. 2003. Effects on Connective Tissue Structures, p 441-449. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch27
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1
Figure 1

Tenocytes from rat achilles tendons. (A) Rat was treated orally with the vehicle from day 32 to day 36 postnatally. (B) Rat was treated orally with 600 mg ciprofloxacin/kg of body weight from day 32 to day 36 postnatally. In comparison with the controls, cellular as well as matrix alterations are detectable by electron microscopy in tendon samples from quinolone-treated rats. Note the vacuoles and large vesicles in the cytoplasm of tenocytes (arrows) resulting from swellings and dilatations of cell organelles (mitochondria, endoplasmic reticulum). Cells are detached from the matrix, and the fibril diameter is decreased in the ciprofloxacin-treated rats. Similar changes were observed in Achilles tendons after treatment with ofloxacin or garenoxacin. Reprinted from reference 33a with permission.

Citation: Stahlmann R. 2003. Effects on Connective Tissue Structures, p 441-449. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch27
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555817817.chap27
1. Bailey, R. R.,, R. Natale,, and A. L. Linton. 1972. Nalidixic acid arthralgia. Can. Med. Assoc. J. 107: 604 607.
2. Bailey, R. R.,, J . A. Kirk,, and B. A. Peddie. 1983. Norfloxacininduced rheumatic disease. N. Z. Med. J. 96: 590.
3. Casparian, J. M.,, M. Luchi,, R. E. Moffat,, and D. Hinthorn. 2000. Quinolones and tendon ruptures. South. Med. J. 93: 488 491.
4. Christ, W.,, T. Lehnert,, and B. Ulbrich. 1988. Specific toxicologic aspects of the quinolones. Rev. Infect. Dis. 10( Suppl. 1): S141 S146.
5. Fassheber, S.,, E.-M. Kappel,, K. Riecke,, U. Rahm,, M. Shakibaei,, and R. Stahlmann. 2001. Chondrotoxicity of ofloxacin compared with BMS-284756 in juvenile rats, abstr. no. 2207. In Program and Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C..
6. Forster, C.,, K. Kociok,, M. Shakibaei,, H.-J. Merker,, and R. Stahlmann. 1996. Quinolone-induced cartilage lesions are not reversible in rats. Arch. Toxicol. 70: 474 481.
7. Forster, C.,, K. Kociok,, M. Shakibaei,, H.-J. Merker,, J. Vormann,, T. Giinther,, and R. Stahlmann. 1996. Integrins on joint cartilage chondrocytes and alterations by ofloxacin or magnesium deficiency in immature rats. Arch. Toxicol. 70: 261 270.
8. Forster, C.,, R. Schwabe,, E. Lozo,, U. Zippel,, J. Vormann,, T. Giinther,, H.-J. Merker,, and R. Stahlmann. 1997. Quinoloneinduced arthropathy: Exposure of magnesium-deficient aged rats or immature rats, mineral concentrations in target tissues and pharmacokinetics. Arch. Toxicol. 72: 26 32.
9. Gajjar, D. A.,, D. M. Grasela,, A. Bello,, Z. Ge,, and L. Christopher. 2000. Safety, tolerability, and pharmacokinetics of BMS-284756, a novel des-F(6(-quinolone, following single oral doses in healthy adult subjects, abstr. 2259. In Progress and Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C..
10. Hampel, B.,, R. Hullmann,, and H. Schmidt. 1997. Ciprofloxacin in pediatrics: worldwide clinical experience based on compassionate use: safety report. Pediatr. Infect. Dis. 16: 127 129.
11. Hayem, G.,, P. X . Petit,, M. Levacher,, C. Gaudin,, M. E. Kahn,, and J . J . Pocidalo. 1994. Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial agents. Antimicrob. Agents Chemother. 38: 243 247.
12. Huddleston, P.M.,, J . M. Steckelberg,, A. D. Hanssen,, M. S. Rouse,, M. E. Bolander,, and R. Patel. 2000. Ciprofloxacin inhibition of experimental fracture healing. J. Bone Joint Surg. Am. 82: 161 173.
13. Ingham, B.,, D. W. Brentnall,, E. A. Dale,, and J . A. McFadzean. 1977. Arthropathy induced by antibacterial fused N-alkyl-4- pyridone-3-carboxylic acids. Toxicol. Lett. 1: 21 26.
14. Jones, N.,, and C. M. Kjellstrand. 1996. Spontaneous tendon ruptures in patients on chronic dialysis. Am. J. Kidney Dis. 28: 861 866.
15. Kahn, M.-F.,, and G. Hayem. 1997. Tendons and fluoroquinolones. Unresolved issues. Rev. Rhum. (English Edition) 64: 437 439.
16. Kashida, Y.,, and M. Kato. 1997. Characterization of fluoroquinolone- induced Achilles tendon toxicity in rats: comparison of toxicities of 10 fluoroquinolones and effects of antiinflammatory compounds. Antimicrob. Agents Chemother. 41: 2389 2393.
17. Kato, M.,, and T. Onodera. 1988. Morphological investigation of cavity formation in articular cartilage induced by ofloxacin in rats. Fund. Appl. Toxicol. 11: 110 119.
18. Kato, M.,, S. Takada,, Y. Kashida,, and M. Nomura. 1995. Histological examination on Achilles tendon lesions induced by quinolone antibacterial agents in juvenile rats. Toxicol. Pathol. 23: 385 392.
19. Kawamura, Y.,, A. Nagai,, M. Miyazaki,, T. Sanzen,, H. Fukumoto,, H. Hayakawa,, Y. Todo,, N. Terashima,, Y. Watanabe,, and H. Narita. 2000. Articular toxicity of BMS- 284756 (T-3811ME) administered orally to juvenile dogs, 448 STAHLMANN poster 277. In Program and Abstracts of the 40th Inter science Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C..
20. Lawrence, L.E.,, P. Wu,, L. Fran,, K. Gouveia,, A. Card,, K. Denbleyker,, and J . F. Barrett. 2000. The structure-activity relationship of BMS-284756, a novel des-F(6(-quinolone, poster No. 751. In Program and Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C..
21. McDonald, D., F. H. B. Short. 1964. Usefulnes of nalidixic acid in treatment of urinary infection. Antimicrob. Agents Chemother. 4: 628 631.
22. Pertuiset, E.,, G. Lenoir,, M. Jehanne,, F. Douchan,, M. Guillot,, and C. J . Menkes. 1989. Tolerance articulaire de la pefloxacine et de l'ofloxacine chez les enfants et adolescents atteints de mucoviscidose. Rev. Rhum. 56: 735 740.
23. Pierfitte, C.,, and R. J. Royer. 1996. Tendon disorders with fluoroquinolones. Therapie 51: 419 420.
24. Pfizer. 1996. Trovafloxacin Investigator's Brochure. Pfizer, Groton, Conn..
25. Riecke, K.,, E. Lozo,, M. Shakibaei,, I. Baumann-Wilschke,, and R. Stahlmann. 2000. Fluoroquinolone-induced lesions in the epiphyseal growth plates of immature rats, abstr. 276. In Program and Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C..
26. Rock. E.,, C. Astier,, C. Lab,, C. Malpuech,, W. Nowacki,, E. Gueux,, A. Mazur,, and Y. Rayssiguier. 1995. Magnesium deficiency in rats induces a rise in plasma nitric oxide. Magnes. Res. 8: 37 242.
27. Saint, F.,, G. Gueguen,, J. Biserte,, C. Fontaine,, and E. Mazeman. 2000. Rupture of the patellar ligament one month after treatment with fluoroquinolone. Rev. Chir. Orthop. Reparatrice Appar. Mot. 86: 495 497.
28. Schaad. U.,, J. Wedgwood,, A. Ruedeberg,, R. Kraemer,, and B. Hampel. 1997. Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis. Pediatr. Infect. Dis. J. 16: 106 111.
29. Schaad, U. B., 2000. Use of the quinolones in pediatrics, p. 455 475. In V. T. Andriole (ed.), The Quinolones, 3rd ed. Academic Press, San Diego, Calif..
30. Schwabe, R.,, E. Lozo,, I. Baumann-Wilschke,, and R. Stahlmann. 1999. Chondrotoxicity and target tissue kinetics of ofloxacin in immature rats after multiple doses. Drugs 58( Suppl. 2): 385 387.
31. Shakibaei, M.,, K. Kociok,, C. Forster,, J . Vormann,, T. Gunther,, R. Stahlmann,, and H.-J. Merker. 1996. Comparative evaluation of ultrastructural changes in articular cartilage of juvenile rats after treatment with ofloxacin and in magnesium-deficient rats. Toxicol. Pathol. 24: 580 587.
32. Shakibaei, M.,, K. Pfister,, R. Schwabe,, J . Vormann,, and R. Stahlmann. 2000. Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet. Antimicrob. Agents Chemother. 44: 261 266.
33. Shakibaei, M.,, and R. Stahlmann. 2001. Ultrastructure of Achilles tendon from rats after treatment with fleroxacin. Arch. Toxicol. 75: 97 102.
33a.. Shakibaei, M.,, and R. Stahlmann. Ultrastructural changes induced by the des-F(6)-quinolone garenoxacin (BMS- 284756) and two fluoroquinolones in Achilles tendon from immature rats. Arch. Toxicol., in press.
34. Shakibaei, M.,, I. Baumann-Wilschke,, R. Stahlmann. 2001. Quinolone-induced changes in Achilles tendons from rats persist for several months. J. Antimicrob. Chemother. 47( Suppl. Sl): 49. (Poster P130.).
35. Shakibaei, M.,, P. de Souza,, D. van Sickle,, and R. Stahlmann. 2001. Biochemical changes in Achilles tendon from juvenile dogs after treatment with ciprofloxacin or feeding a magnesium- deficient diet. Arch. Toxicol. 75: 369 374.
36. Shakibaei, M.,, E.-M. Kappel,, I. Baumann-Wilschke,, and R. Stahlmann. 2001. Effects of BMS-284756, ofloxacin and ciprofloxacin on the ultrastructure of Achilles tendon in juvenile rats, abstr. 1662. In Program and Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C..
37. Shinohara, Y. T.,, S. A. Tasker,, M. R. Wallace,, K. E. Couch,, and P. E. Olson. 1997. What is the risk of Achilles tendon rupture with ciprofloxacin? / . Rheumatol. 24: 238 239.
38. Simonin, M. A.,, P. Gegout-Pottie,, A. Minn,, P. Gillet,, P. Netter,, and B. Terlain. 1999. Proteoglycan and collagen biochemical variations during fluoroquinolone-induced chondrotoxicity in mice. Antimicrob. Agents Chemother. 43: 2915 2921.
39. Simonin, M. A.,, P. Gegout-Pottie,, A. Minn,, P. Gillet,, P. Netter,, and B. Terlain. 2000. Pefloxacin-induced Achilles tendon toxicity in rodents: biochemical changes in proteoglycan synthesis and oxidative damage to collagen. Antimicrob. Agents Chemother. 44: 867 872.
40. Stahlmann, R.,, H.-J. Merker,, N. Hinz,, J . Webb,, W. Heger,, and D. Neubert. 1990. Ofloxacin in juvenile non-human primates and rats. Arthropathia and drug plasma concentrations. Arch. Toxicol. 64: 193 204.
41. Stahlmann, R.,, C. Forster,, M. Shakibaei,, J . Vormann,, T. Gunther,, and H.-J. Merker. 1995. Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical with quinolone-induced arthropathy. Antimicrob. Agents Chemother. 39: 2013 2018.
42. Stahlmann, R.,, J . Vormann,, T. Gunther,, C. Forster,, U. Zippel,, E. Lozo,, R. Schwabe,, K. Kociok,, M. Shakibaei,, and H.-J. Merker. 1997. Effects of quinolones, magnesium deficiency or zinc deficiency on joint cartilage in rats. Magnes. Bull. 19: 7 22.
43. Stahlmann, R.,, U. Zippel,, C. Forster,, M. Shakibaei,, H.-J. Merker,, K. and Boraer. 1998. Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats. Antimicrob. Agents Chemother. 42: 1470 1475.
44. Stahlmann, R.,, R. Schwabe,, K. Pfister,, E. Lozo,, M. Shakibaei,, and J. Vormann. 1999. Supplementation with magnesium and tocopherol diminishes quinolone-induced chondrotoxicity in immature rats. Drugs 58( Suppl. 2): 393 394.
45. Stahlmann, R.,, S. Kuhner,, M. Shakibaei,, R. Schwabe,, J . Flores,, S. A. Evander,, and D. C. van Sickle. 2000. Chondrotoxicity of ciprofloxacin in immature Beagle dogs; immunohistochemistry, electron microscopy and drug plasma concentrations. Arch. Toxicol. 73: 564 572.
46. Stahlmann, R.,, S. Kuhner,, M. Shakibaei,, J . Flores,, J . Vormann,, and D. C. van Sickle. 2000. Effects of magnesium deficiency on joint cartilage in immature Beagle dogs: immunohistochemistry, electron microscopy and mineral concentrations. Arch. Toxicol. 73: 573 580.
47. Stahlmann, R. 2001. Clinical toxicological aspects of fluoroquinolones. EUROTOX 2001, Istanbul. Toxicol. Lett., in press.
48. Syllm-Rapoport, I.,, I. Strassburger,, D. Griineberg,, and C. Zirbel. 1958. Uber den experimentellen Magnesium-Mangel beim Hund. Acta Biol. Med. Germ. 1: 141 163.
49. Tatsumi, H.,, H. Senda,, S. Yatera,, Y. Takemoto,, M. Yamayoshi,, and K. Ohnishi. 1978. Toxicological studies on pipemidic acid. V. Effect on diarthrodial joints of experimental animals. J . Toxicol. Sci. 3: 357 367.
50. Takizawa, T.,, K. Hasimoto,, T. Minami,, S. Yamashita,, K. Owen. 1999. The comparative arthropathy of fluoroquinolones in dogs. Hum. Exp. Toxicol. 18: 392 399.
51. Takizawa, T.,, K. Hasimoto,, N. Itoh,, S. Yamashita,, and K. Owen. 1999. A comparative study of the repeat dose toxicity of grepafloxacin and a number of other fluoroquinolones in rats. Hum. Exp. Toxicol. 18: 38 45.
52. Van der Linden. P. D.,, J. van de Lei,, H. W. Nab,, A. Knol,, and B. H. Ch. Strieker 1999. Achilles tendinitis associated with fluoroquinolones. Br. J. Clin. Pharmacol. 48: 433 437.
53. VanderLinden, P. D.,, E. P. vanPuijenbroek,, J . Feenstra,, B. A. Veld,, M. C. Sturkenboom,, R. M. Herings,, H. G. Leufkens,, and B. H. Strieker. 2001. Tendon disorders attributed to fluoroquinolones: a study on 42 spontaneous reports in the period 1988 to 1998. Arthritis Rheum. 45: 235 239.
54. vonKeutz, E.,, and G. Schluter. 1999. Preclinical safety evaluation of moxifloxacin, a novel fluoroquinolone. J. Antimicrob. Chemother. 43( Suppl. B): 91 100.
55. Vormann, J.,, C. Forster,, U. Zippel,, E. Lozo,, T. Giinther,, H. - J . Merker, and R. Stahlmann. 1997. Effects of magnesium deficiency on magnesium and calcium content in bone and cartilage in developing rats in correlation to chondrotoxicity. Calcif. Tissue Int. 61: 230 238.

Tables

Generic image for table
Table 1

Toxic effects of quinolones on connective tissue structures

Citation: Stahlmann R. 2003. Effects on Connective Tissue Structures, p 441-449. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch27
Generic image for table
Table 2

Risk for Achilles tendinitis by fluoroquinolones compared with other antibacterial agents

Citation: Stahlmann R. 2003. Effects on Connective Tissue Structures, p 441-449. In Hooper D, Rubinstein E (ed), Quinolone Antimicrobial Agents, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555817817.ch27

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error